Clinical Research Directory
Browse clinical research sites, groups, and studies.
Remote vs. In-Person Study Evaluation (RISE) Trials: RISE Above Smoking (Trial 1)
Sponsor: State University of New York at Buffalo
Summary
The study will employ a randomized, parallel-group design with two-stage randomization. After an initial brief screen for basic eligibility, participants will be randomized (within site) to either Remote (R) or In-Person (IP) Intake Groups. During the Intake, detailed consent and eligibility assessment will be completed. Participants who are eligible at the Intake will be randomized (within site and Intake Group) to R or IP Treatment and Assessment Groups. Participants will be followed for 3 months.
Official title: Improving Efficiency, Quality, and Equity: Randomized Controlled Evaluations of Remote vs. In-Person Clinical Trial Methods; Remote vs. In-Person Study Evaluation (RISE) Trials
Key Details
Gender
All
Age Range
18 Years - 99 Years
Study Type
INTERVENTIONAL
Enrollment
200
Start Date
2025-03-10
Completion Date
2027-02-28
Last Updated
2026-01-14
Healthy Volunteers
Yes
Interventions
Combination Nicotine Replacement Therapy (patch and lozenge)
All participants receive 8 weeks of combination nicotine replacement therapy - long-acting transdermal patch and short-acting lozenge.
Locations (2)
University at Buffalo
Buffalo, New York, United States
University of Pennsylvania
Philadelphia, Pennsylvania, United States